Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis

被引：0
|
作者：
Luz, Martim [1 ]
Torres, Tiago [1 ,2 ]
机构：
[1] Unidade Local Saude Santo Antonio, Dept Dermatol, Porto, Portugal
[2] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal
来源：
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 2024年 / 25卷 / 06期
关键词：
D O I：
10.1007/s40257-024-00894-9
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1019 / 1021
页数：3
相关论文
共 50 条
  • [1] CLINICAL PREDICTORS OF IL-17 AND IL-23 INHIBITORS DOSE SPACING IN ADULT PSORIATIC PATIENTS: A REAL-WORLD PILOT STUDY
    Mastorino, Luca
    Dapavo, Paolo
    Ribero, Simone
    Quaglino, Pietro
    Ortoncelli, Michela
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [2] IL-23 Inhibitors for Psoriasis
    Beck K.M.
    Yang E.J.
    Sekhon S.
    Bhutani T.
    Current Dermatology Reports, 2018, 7 (2) : 119 - 124
  • [3] Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
    Gargiulo, Luigi
    Ibba, Luciano
    Malagoli, Piergiorgio
    Balato, Anna
    Bardazzi, Federico
    Burlando, Martina
    Carrera, Carlo G.
    Damiani, Giovanni
    Dapavo, Paolo
    Dini, Valentina
    Gaiani, Francesca M.
    Girolomoni, Giampiero
    Guarneri, Claudio
    Lasagni, Claudia
    Loconsole, Francesco
    Marzano, Angelo V.
    Megna, Matteo
    Mercuri, Santo R.
    Travaglini, Massimo
    Costanzo, Antonio
    Narcisi, Alessandra
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [4] Selective Il-23 Inhibitors: The New Kids on the Block in the Treatment of Psoriasis
    Torres, T.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (08): : 674 - 676
  • [5] Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience
    Borghi, Alessandro
    Odorici, Giulia
    Bardazzi, Federico
    Filippi, Federica
    Bigi, Laura
    Lasagni, Claudia
    Manfredini, Marco
    Di Lernia, Vito
    Peccerillo, Francesca
    Conti, Andrea
    Tiberio, Rossana
    Satolli, Francesca
    Fantini, Carolina
    Rovesti, Miriam
    Gasperini, Massimo
    Tabanelli, Michela
    D'Adamio, Simone
    Flacco, Maria Elena
    Corazza, Monica
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (03):
  • [6] TREATMENT OF PSORIASIS: ANALYSIS OF REAL-WORLD EVIDENCE
    Karbusicka, M.
    Duba, J.
    Kolek, M.
    VALUE IN HEALTH, 2019, 22 : S911 - S912
  • [7] Risk of fungal infection in psoriasis patients treated with IL-17 and IL-23 inhibitors: a multi-cohort study using real-world data
    Islam, Rahib K.
    Maltese, Alexander
    Lipner, Shari R.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [8] IL-23 inhibitors for moderate-to-severe psoriasis
    Ibler, Erin
    Gordon, Kenneth B.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 158 - 162
  • [9] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Hadeler, Edward
    Mosca, Megan
    Hong, Julie
    Brownstone, Nicholas
    Bhutani, Tina
    Liao, Wilson
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (01) : 6 - 15
  • [10] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Edward Hadeler
    Megan Mosca
    Julie Hong
    Nicholas Brownstone
    Tina Bhutani
    Wilson Liao
    Current Dermatology Reports, 2021, 10 : 6 - 15
12345